Lv1
30 积分 2025-08-29 加入
Development of a liver disease–specific large language model chat interface using retrieval-augmented generation
1个月前
已完结
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
5个月前
已完结
Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B
5个月前
已完结
The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study
5个月前
已完结
BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers
5个月前
已完结
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually
5个月前
已完结
Reply: Aspirin and GLP-1RAs—The missing confounders of empagliflozin for MASLD without diabetes mellitus?
6个月前
已关闭
Reply: Aspirin and GLP-1RAs—The missing confounders of empagliflozin for MASLD without diabetes mellitus?
6个月前
已关闭
Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
6个月前
已完结
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
8个月前
已完结
皖公网安备34019202002308
